Literature DB >> 6988111

Acid phosphatase in Gaucher's disease.

D B Robinson, R H Glew.   

Abstract

Increased acid phosphatase activity in the serum and tissues of patients with Gaucher's disease has now been recognized for two decades, but as yet no relation has been established between the enzyme and the etiology and progress of the disease. Here, we review results obtained by various investigators, ranging from a consideration of the methods used for the evaluation of serum acid phosphatase in Gaucher's disease to the most recent findings regarding the purification and characterization of two acid phosphatase isoenzymes from the spleen from patients with Gaucher's disease. We also discuss the intracellular location of tissue acid phosphatase in patients with Gaucher's disease and its contribution to the increased activity in serum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988111

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

Review 1.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

2.  Tartrate-resistant acid phosphatase from human osteoclastomas is translated as a single polypeptide.

Authors:  A R Hayman; A J Dryden; T J Chambers; M J Warburton
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

3.  Inactivation of solubilised fusicoccin-binding sites by endogenous plant hydrolases.

Authors:  P Aducci; A Ballio; L Fiorucci; E Simonetti
Journal:  Planta       Date:  1984-04       Impact factor: 4.116

4.  Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher disease patients.

Authors:  W R den Tandt; F van Hoof
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  Variation in four acid hydrolase activities in filarial-susceptible and -refractory genotypes of Aedes aegypti.

Authors:  D Nasr-Schirf; P H Rodriguez; V R Schirf; C I Gonzalez; M Tamayo
Journal:  Biochem Genet       Date:  1989-10       Impact factor: 1.890

6.  Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus.

Authors:  A J Bune; A R Hayman; M J Evans; T M Cox
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

Review 7.  Screening for lysosomal disorders.

Authors:  K Ullrich
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

8.  A high-molecular weight complex with acid phosphatase activity in human breast cancer.

Authors:  O L Podhajcer; J E Filmus; N Guman; J Mordoh
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

9.  Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.

Authors:  R Torres; C de la Piedra; A Rapado
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

10.  Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas.

Authors:  A R Hayman; M J Warburton; J A Pringle; B Coles; T J Chambers
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.